Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Diagn Pathol Open 2016, Vol 1(1): 103
  • DOI: 10.4172/2476-2024.1000103

Proteomic Biomarkers in Alzheimer's disease

Ramón Cacabelos1,2*
1Chair of Genomic Medicine, Camilo José Cela University, , Madrid, Spain
2Institute of Medical Science and Genomic Medicine, EuroEspes Biomedical Research Center, , Corunna, Spain
*Corresponding Author : Ramón Cacabelos, EuroEspes Biomedical Research Center, Institute of Medical Science and Genomic Medicine, Camilo José Cela University, 15165-Bergondo, Corunna, Spain, Tel: +34981780505, Fax: +34981780511, Email: rcacabelos@euroespes.com

Received Date: Dec 02, 2015 / Accepted Date: Dec 24, 2015 / Published Date: Jan 02, 2016

Citation: Cacabelos R (2016) Proteomic Biomarkers in Alzheimer’s disease. Diagn Pathol Open 1: 103. Doi: 10.4172/2476-2024.1000103

Copyright: © 2015 Cacabelos R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Review summary

  1. May Henry
    Posted on Aug 24 2016 at 2:24 pm
    The short communication provides a brief overview of diagnostic biomarkers for Alzheimer's Disease. The author discussed the biomarkers involved in Alzheimer’s disease. The author said that Aβ1-42 in CSF is a valuable marker in AD and also discussed the limitations its use as a diagnostic and prognostic parameter.
Top